Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition
The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]
Patients to Have Earlier Access to Cutting-edge Treatments on NHS
NHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks […]
NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer
A targeted new drug for a rare and aggressive form of lung cancer will be […]
Life-extending Injection for Blood Cancer Available on the NHS
A life-extending injection for a fatal form of blood cancer will be available to around […]
Immunotherapy Approved for Some People with Oesophageal Cancer on NHS in England
The National Institute for Health and Care Excellence (NICE) has recommended the use of the […]
New Collaboration Between NICE and AHSN will Help Embed Innovations into the Healthcare System for the Benefit of Patients
NICE and the Academic Health Science Network (AHSN) have today (4 August) announced a two-year […]
New Drug Combo for Advanced Breast Cancer Approved for NHS in England
The National Institute of Health and Care Excellence (NICE) has approved the use of a […]
First Treatment Approved in England for Advanced Bile Duct Cancer
The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]
Digital Healthcare Company Healios Gets £7M to Offer Tailored Therapy to Children and Young People Across the UK
Based out of Southampton, Healios is a digital healthcare company working to empower patients and families affected […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more